Study guide
6.1 Cognitive Impairment Risk Recognition
ANCC Gerontological Nursing Certification GERO-BC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the GERO-BC Exam 1.2 Eligibility, Fees, Scoring & Testing 1.3 How to Study for GERO-BC
2 Assessment Tools: Physical & Psychosocial
2.1 Fall, Depression & Pressure-Injury Risk Tools 2.2 Cognitive Assessment Tools (MMSE, MoCA, SLUMS, CAM) 2.3 Functional (ADL/IADL) & Pain Assessment
3 Social Determinants & Care Context
3.1 Social Determinants of Health in Aging 3.2 Caregiver & Support-System Assessment 3.3 Living Environment & Access Barriers
4 Pharmacotherapy Assessment
4.1 Polypharmacy Identification & Medication Review 4.2 Drug Interactions in Older Adults 4.3 Pharmacokinetic Changes with Aging
5 Aging Physiology & Clinical Findings
5.1 Sensory & Neurological Aging Changes 5.2 Circulatory & Cardiopulmonary Aging 5.3 Distinguishing Normal Aging from Pathology
6 Risk Factor Identification
6.1 Cognitive Impairment Risk Recognition 6.2 Non-Adherence Risk Factors 6.3 Elder Abuse & Neglect Screening
7 Evidence-Based Interventions
7.1 Evidence-Based Interventions & Expected Outcomes 7.2 Chronic Disease Management in Older Adults 7.3 Delirium Prevention & Dementia Care 7.4 Depression Care & Palliative/Hospice Care
8 Medications, Beers Criteria & Contraindications
8.1 Beers Criteria Essentials 8.2 Dosage & Route Modifications for Older Adults 8.3 Food, Drug & Herbal Contraindications
9 Care Planning & Prioritization
9.1 Nursing Diagnosis & Problem-List Evaluation 9.2 Person-Centered Care Planning 9.3 Outcome Evaluation & Plan Revision
10 Safety & Therapeutic Environment
10.1 Fall Prevention Interventions 10.2 Restraint Alternatives, Infection Control & Skin Integrity 10.3 Therapeutic Environment & Milieu Management 10.4 Wound Care Essentials for Older Adults
11 Care Coordination Across the Continuum
11.1 Transitions of Care 11.2 Case Management & Community Resources 11.3 Caregiver Support Systems
12 Theories, Prevention & Health Promotion
12.1 Theoretical Frameworks in Gerontology 12.2 Disease Prevention & Screenings 12.3 Immunizations & Preventive Care for Older Adults 12.4 Self-Management & Health Promotion Strategies
13 Communication & Adult Learning
13.1 Principles of Adult Learning 13.2 Communication Barriers & Adaptations 13.3 Patient & Family Education
14 Diversity, Ethics & Legal Practice
14.1 DEI & Older-Adult Subpopulations 14.2 Advance Directives & Surrogate Decision-Making 14.3 Ethics, Advocacy & Scope of Practice 14.4 Capacity & Informed Consent
15 Regulation, QI & Technology
15.1 CMS & Regulatory Compliance 15.2 Quality Improvement in Gerontological Settings 15.3 EHR & Documentation Standards 15.4 Telehealth, Remote Monitoring & Hospital-at-Home
6.1 Cognitive Impairment Risk Recognition
Key Takeaways Explain This Topic AI
Cognitive impairment risk includes nonmodifiable factors (age, genetics, prior TBI) and modifiable factors (vascular disease, hearing loss, depression, isolation, sleep apnea, sensory deprivation, medications)
Distinguish delirium risk (acute, fluctuating, often reversible precipitants) from progressive dementia risk and from depression-related cognitive complaints
Early red flags—new missed appointments, medication errors, getting lost, word-finding decline, unpaid bills—warrant structured screening and workup for reversible causes
Risk recognition drives earlier MoCA/MMSE/SLUMS or CAM use, safety planning, and caregiver engagement—not an automatic dementia diagnosis
Last updated: August 2026
ANCC GERO-BC Domain I (Assessment and Diagnosis), knowledge area I-B-2 (risk factor identification) , expects you to recognize who is at elevated risk for cognitive decline—and to act before crises force recognition. Cognitive impairment risk identification is not the same as diagnosing dementia. Your job is to detect vulnerability early, separate acute reversible syndromes from progressive neurodegenerative patterns, and escalate screening, safety measures, and interdisciplinary evaluation when risk clusters appear.
Why Risk Recognition Matters
Undetected cognitive decline drives falls, medication nonadherence, financial exploitation, missed diagnoses, hospital readmissions, and caregiver burnout. Many older adults compensate for years with calendars, spouses who “fill in” answers, and simplified routines. Risk recognition helps you look behind that compensation.
Treat cognitive risk as multifactorial . A single risk factor rarely predicts impairment by itself; clusters of vascular, sensory, psychosocial, and pharmacologic risks raise concern sharply.
Nonmodifiable and Modifiable Risk Factors
Category Examples Clinical implication
Nonmodifiable Advanced age, APOE ε4 or strong family history, prior moderate–severe traumatic brain injury, Down syndrome Heighten surveillance; do not dismiss early complaints as “normal aging”
Vascular / cardiometabolic Hypertension, diabetes, atrial fibrillation, stroke/TIA, obesity, smoking, hyperlipidemia Aggressive risk-factor control may slow vascular cognitive decline
Sensory Untreated hearing loss, vision impairment Increases cognitive load; hearing loss is a major modifiable dementia risk factor in population studies
Neuropsychiatric Late-life depression, anxiety, chronic sleep disturbance, untreated OSA Mood and sleep disorders both mimic and amplify cognitive decline
Social / educational Low educational attainment, social isolation, limited cognitive stimulation Lower cognitive reserve; isolation accelerates functional loss
Toxic / iatrogenic Anticholinergics, benzodiazepines, opioids, polypharmacy, alcohol misuse Reversible contributors—always review the medication list
Medical precipitants Hypothyroidism, B12 deficiency, hyponatremia, infection, uncontrolled pain, hypoxia Especially important when decline is subacute
High-yield modifiable targets for nursing assessment
Hearing and vision — ask about TV volume, missed conversation, unread mail; refer for audiology/optometry when deficits appear.
Vascular control — trend BP, A1C, anticoagulation adherence after AF/stroke.
Deprescribing risk — flag Beers-criteria CNS-active drugs that cloud attention and memory.
Sleep apnea clues — loud snoring, daytime somnolence, resistant hypertension, witnessed apneas.
Isolation — living alone after bereavement, no phone contact, missed meals delivered by others.
Exam cue: Items often pair a “forgetful” older adult with a reversible driver (new benzodiazepine, untreated hearing loss, UTI with fluctuating attention). Identify the risk cluster before labeling permanent dementia.
Delirium Risk vs Dementia Risk vs Depression
GERO-BC repeatedly tests whether you can tell syndrome patterns apart while still recognizing overlapping risk.
- Feature Delirium risk pattern Progressive dementia risk pattern Depression-related cognitive complaints
- Onset Hours to days Months to years Weeks to months, often with mood change
- Course Fluctuating; worse at night Gradual decline (stepwise if vascular) May improve with mood treatment
- Attention Markedly impaired Relatively preserved early Variable; often “I don’t know” answers
Awareness Often reduced awareness of deficits Early anosognosia common later Patients often distressed by deficits
Key risks Infection, surgery, drugs, ICU, sensory deprivation, restraint, immobility Age, vascular burden, neurodegeneration genetics Prior depression, isolation, loss, pain
- Delirium-specific risk factors to identify early
- Age ≥65, preexisting cognitive impairment, sensory impairment
- Polypharmacy / new psychoactive medication
- Infection, dehydration, electrolyte imbalance, hypoxia, uncontrolled pain
- Immobilization, restraints, disrupted sleep–wake cycle
- Surgery (especially orthopedic/cardiac), ICU stay, Foley catheter
Use tools such as CAM/CAM-ICU when acute change plus inattention appear. Delirium risk identification is preventive: minimize tethers, restore glasses/hearing aids, optimize sleep, review meds, and mobilize.
Dementia-spectrum risk recognition
For progressive impairment risk, watch for instrumental ADL erosion (finances, meds, driving, cooking) before basic ADLs fail. Vascular risk clustering suggests mixed or vascular cognitive impairment. Rapid week-to-week decline is atypical for typical Alzheimer disease and should push workup for delirium, infection, subdural hematoma, medication toxicity, or other acute processes.
Depression as both risk and mimic
Late-life depression increases later dementia risk and can present with concentration and memory complaints (“pseudodementia” is an outdated oversimplification—screen for both). Positive GDS/PHQ plus cognitive complaints means treat mood and reassess cognition after mood improves; do not assume permanent dementia from a single depressed assessment.
Early Clinical Red Flags
Risk identification often starts with collateral history and functional clues rather than a formal score.
- Functional and behavioral red flags
- Repeating questions within the same visit; losing the thread of conversation
- Missed appointments, wrong-day arrivals, or inability to recount recent events
- New medication errors, duplicate fills, or unexplained subtherapeutic levels
- Unpaid bills, unusual purchases, or susceptibility to phone scams
- Getting lost on familiar routes; GPS dependence that is new
- Decline in cooking, shopping, or medication management (IADL failure)
- Word-finding pauses that worsen; difficulty following multistep instructions
- Personality change, apathy, or new disinhibition (frontotemporal clues)
- Caregiver saying “they’re just not themselves” with concrete examples
- When to escalate beyond watchful waiting
Escalate structured cognitive screening and medical evaluation when:
The person or caregiver reports progressive decline affecting function.
Safety risks appear (driving near-misses, stove left on, wandering).
Acute fluctuation suggests delirium until proven otherwise.
New psychoactive medications or metabolic abnormalities coincide with decline.
Decision-making capacity for treatment or discharge is uncertain.
Document baseline cognition whenever possible—admission MoCA/MMSE/SLUMS or a clear description of orientation, attention, and IADL status—so later change is measurable.
Reversible and Partially Reversible Contributors
Always ask: What could be reversible here? Classic “treatable” contributors include:
- Contributor Clues Nursing action
- Medications (anticholinergics, sedatives) Temporal link to new drug Med reconciliation; flag for deprescribing
- Delirium precipitants Acute illness, hospital stressors CAM screen; treat cause; nonpharm delirium bundle
B12 / folate / thyroid disorders Fatigue, neuropathy, bradycardia, weight change Ensure labs ordered; teach importance of follow-up
- Depression / grief Anhedonia, sleep/appetite change Mood screen; safety assessment; referral
- Hearing/vision loss Social withdrawal, “confusion” in groups Sensory aids on; specialty referral
- Sleep apnea Daytime sleepiness, resistant HTN Screen symptoms; encourage sleep study
- Alcohol / cannabis / OTC misuse Hidden use, falls, INR instability Nonjudgmental substance history
- Nursing Role: From Risk to Action
Risk recognition without action is incomplete assessment.
Screen appropriately — MoCA/MMSE/SLUMS for suspected chronic decline; CAM for acute change; depression tools by cognition level.
Protect safety — falls, wandering, medication mismanagement, financial vulnerability, driving concerns.
Engage caregivers — obtain collateral; teach warning signs; assess caregiver stress.
Address modifiable risks — hearing aids, vascular control, sleep, socialization, deprescribing.
Coordinate — primary care, geriatrics, neurology, pharmacy, social work, audiology as indicated.
Avoid premature labeling — document observations and scores; reserve diagnostic language for the evaluating clinician/team.
Exam Focus
GERO-BC items on cognitive impairment risk typically ask which factor most increases risk, which finding suggests delirium rather than dementia, or what the nurse should do next after identifying red flags. Prioritize reversible contributors, safety, and the correct screening pathway over jumping to a permanent dementia label.